Showing results (2981-2990 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 18, 2002
A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinomaM Pawlicki, J Rolski, J Zaluski, et al.
The Oncologist|June 18, 2002
Unique features of the mode of action of ET-743Maurizio D'Incalci, Eugenio Erba, Giovanna Damia, et al.
The Oncologist|June 18, 2002
Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trialsBetty A Mincey, Frances M Palmieri, Edith A Perez
The Oncologist|August 31, 2002
ZD1839 (Iressa): what's in it for the patient?Ronald B Natale, Susan L Zaretsky
The Oncologist|February 3, 2019
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell CarcinomaDaniel Reinhorn, Michal Sarfaty, Moshe Leshno, et al.
The Oncologist|December 6, 2019
Emmanuel Levinas: A Doctrine for DoctorsBenjamin W Corn, Eli Sharon, Elisabeth Goldwyn
The Oncologist|December 13, 2019
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract CarcinomaSakti Chakrabarti, Tyler J Zemla, Daniel H Ahn, et al.
The Oncologist|February 8, 2020
Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal CancerCarling Ursem, Margaret Zhou, Alan Paciorek, et al.
The Oncologist|February 25, 2020
Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the LiteratureMiruna Grecea, Aurélien Marabelle, Samy Ammari, et al.
The Oncologist|February 12, 2020
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine TherapyPeter A Kaufman, Masakazu Toi, Patrick Neven, et al.
Pageof 571